Microbial Identification Methods Market Scope And Analysis

Microbial Identification Methods Market Report Scope

Industry Developments and Future Opportunities: 

Various initiatives taken by key players operating in the global microbial identification methods market are listed below:

1. In June 2023, Biolog Inc announced the acquisition of MIDI Labs and MIDI, Inc., both headquartered in Newark, Delaware. Over the last two decades, both companies have served the microbial ID community, offering complementary products and services. MIDI Labs is an innovator in microbial identification that currently offers contract laboratory services for microbial identification and enumeration to deliver critical, time-sensitive ID for pharmaceutical, probiotic, food and beverage, and personal care manufacturing operations using sequencing and MALDI-TOF mass spectrometry. 
2. In April 2023, Bruker Corporation launched the fast next-generation MALDI Biotyper IVD Software and optimized MBT Mycobacteria IVD Kit and MBT HT Filamentous Fungi IVD Module. The launch is expected to complement the company's user-friendly, best-in-class diagnostic solutions for routine clinical microbiology and infection diagnostics laboratories.
3. In July 2022, Accelerate Diagnostics Inc announced CE marking of its new Accelerate Arc Module and BC kit. Designed for labs with MALDI platforms, the Accelerate Arc Module and BC kit is a novel application of inline centrifugation and automated sample prep techniques, which, together with the blood culture (BC) kit, provides a suspension of cleaned microbial cells for direct transfer to a MALDI spotting plate.
4. In January 2022, BD received 510(k) clearance from the US Food and Drug Administration (FDA) for the BD Kiestra IdentifA system, designed to automate microbiology bacterial identification testing preparation.
5. In September 2020, Avantor announced a global distribution agreement with Oxford Nanopore Technologies, a market leading manufacturer of next-generation sequencing instruments, kits, and consumables. The agreement enables scientists to have broader access to Oxford Nanopore’s portable real-time nanopore sequencing device, MinION, associated with consumables and reagents.

Competitive Landscape and Key Companies:

Avantor Inc, Becton Dickinson and Co, bioMerieux SA, Merck KGaA, Thermo Fisher Scientific Inc, Bruker Corp, Shimadzu Corp, Accelerate Diagnostics Inc, Molzym GmbH & Co KG, and Biolog Inc are among the prominent players operating in the microbial identification methods. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios.